Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
Revenues | 1,358.0 | 1,815.0 | 958.0 | 277.5 |
Revenue growth | -25.2% | 89.5% | 245.2% | |
Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 |
Gross profit | 1,358.0 | 1,815.0 | 958.0 | 277.5 |
Gross margin | 100.0% | 100.0% | 100.0% | 100.0% |
Sales and marketing | 103.0 | 325.0 | 186.0 | 124.7 |
Research and development | 878.0 | 1,234.0 | 215.0 | 94.9 |
General and administrative | 924.0 | 1,371.0 | 295.0 | 85.5 |
EBITA | -1,002.0 | -3,683.0 | 13.0 | -106.9 |
EBITA margin | -73.8% | -202.9% | 1.4% | -38.5% |
Amortization of intangibles | 9.0 | 3.0 | | |
EBIT | -1,011.0 | -3,686.0 | 13.0 | -106.9 |
EBIT margin | -74.4% | -203.1% | 1.4% | -38.5% |
Pre-tax income | -1,027.0 | -3,685.0 | 13.0 | -107.6 |
Income taxes | 1.0 | 2.0 | 6.0 | -1.0 |
Tax rate | | | 46.2% | 0.9% |
Net income | -1,028.0 | -3,687.0 | 3.0 | -106.6 |
Net margin | -75.7% | -203.1% | 0.3% | -38.4% |
|
Diluted EPS | ($1.17) | ($7.49) | $0.01 | ($0.48) |
Shares outstanding (diluted) | 878.6 | 492.4 | 245.0 | 221.7 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|